Adult Immunization

Latest News

Novavax JN.1 COVID-19 Vaccine Linked to Fewer Side Effects Than mRNA in Health Care Workers
Novavax JN.1 COVID-19 Vaccine Linked to Fewer Side Effects Than mRNA in Health Care Workers

April 22nd 2025

Novavax’s COVID-19 vaccine was linked to fewer and less severe side effects vs mRNA in a University of Utah study of health care workers.

ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years
ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years

April 17th 2025

Second Measles-Related Death in a Child Reported in Texas as US Cases Surpass 600
Second Measles-Related Death in a Child Reported in Texas as US Cases Surpass 600

April 9th 2025

 Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates / image credit ©Kateryna_Kon/stock.adobe.com
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates

April 2nd 2025

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation / Image credit: ©Dr_Microbe - ©Dr_Microbe - stock.adobe.com
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation

March 26th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.